Loading
AA
AroCell AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 19 Jan 2021.
AroCell AB (publ): what insiders have been doing
AroCell AB (publ) is a listed company. Filings by its managers are published through Finansinspektionen. The past year has been quiet: not a single insider filing for AroCell AB (publ). The previous disclosure was published on 19 January 2021.
This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€14,188
2 ops. · all time
Sell Volume
n/a
n/a
Fundamental score
Ranked 21,120 of 24,148 companies
24.7
score / 100
Value16
Quality34
FCF yld-9.2%
Earn yld-12%
EV/EBITDA·
ROE-6.5%
Gross mgn52%
Net mgn-23%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.43
Analyst consensus
1 analystsSEK 1.00Target SEK 1.00(+133%)SEK 1.00
Income statement
RevenueSEK 53.1M
Gross profitSEK 27.7M52% margin
EBITDA-SEK 8.1M-15% margin
Net income-SEK 12.2M-15.4% margin
Valuation
P/Book0.7x
Beta0.90
Balance sheet & cash
Market capSEK 99.1M
Total debtSEK 13.2M
Free Cash Flow-SEK 9.2M
Debt / Equity8%
Profitability & ownership
ROE-6.5%
ROA-3.1%
% insiders41.4%
% institutions2.7%
Last declaration on 19 January 2021
Declarations2 total
20,000 shares@ SEK 2.6656100.0% of flowAktieISIN SE0003883990FI:A001P623-2
Canonical exit: 19 Apr 2021 (T+90)
35,000 shares@ SEK 2.59100.0% of flowAktieISIN SE0003883990FI:A001P609-1
Canonical exit: 18 Apr 2021 (T+90)
2 of 2 declarations
About AroCell AB (publ)
AroCell AB (publ) is a Swedish company focused on developing diagnostic tests for cancer. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
